All Relations between Dementia and microtubule-associated protein tau

Publication Sentence Publish Date Extraction Date Species
Susanna Schraen-Maschke, Claire-Marie Dhaenens, André Delacourte, Bernard Sablonnièr. Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases. Neurobiology of disease. vol 15. issue 3. 2004-05-27. PMID:15056452. the analysis of tau gene and the study of familial cases of tauopathies have led to the discovery of tau gene mutations that cause inherited dementia designated as frontotemporal dementia (ftd) with parkinsonism linked to chromosome 17 (ftdp-17). 2004-05-27 2023-08-12 human
Markus Tolnay, Alphonse Probs. The neuropathological spectrum of neurodegenerative tauopathies. IUBMB life. vol 55. issue 6. 2004-04-22. PMID:12938731. however, tau containing filamentous deposits in neurons and/or glial cells also define a heterogeneous group of neurodegenerative disorders clinically characterized by dementia and/or motor syndromes. 2004-04-22 2023-08-12 Not clear
Peter Schönknecht, Johannes Pantel, Tobias Hartmann, Egon Werle, Martin Volkmann, Marco Essig, Michael Amann, Nadja Zanabili, Hubertus Bardenheuer, Aoife Hunt, Johannes Schröde. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatry research. vol 120. issue 3. 2004-04-21. PMID:14561434. cerebrospinal fluid tau levels in alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. 2004-04-21 2023-08-12 Not clear
Peter Schönknecht, Johannes Pantel, Tobias Hartmann, Egon Werle, Martin Volkmann, Marco Essig, Michael Amann, Nadja Zanabili, Hubertus Bardenheuer, Aoife Hunt, Johannes Schröde. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatry research. vol 120. issue 3. 2004-04-21. PMID:14561434. in contrast, the potential value of tau levels in the differential diagnosis of ad, vascular dementia (vd) and major depression warrants further investigation. 2004-04-21 2023-08-12 Not clear
Dorota Religa, Bengt Winbla. Therapeutic strategies for Alzheimer's disease based on new molecular mechanisms. Acta neurobiologiae experimentalis. vol 63. issue 4. 2004-04-19. PMID:15053264. alzheimer's disease (ad)--the main cause of dementia--is characterized by the presence of neuritic plaques containing the amyloid-beta peptide (a beta) and an intraneuronal accumulation of tubule-associated protein called tau. 2004-04-19 2023-08-12 Not clear
Manabu Wada, Chang-Hong Ren, Shingo Koyama, Shigeki Arawaka, Shinobu Kawakatsu, Hideki Kimura, Hikaru Nagasawa, Toru Kawanami, Keiji Kurita, Makoto Daimon, Asao Hirano, Takeo Kat. A human granin-like neuroendocrine peptide precursor (proSAAS) immunoreactivity in tau inclusions of Alzheimer's disease and parkinsonism-dementia complex on Guam. Neuroscience letters. vol 356. issue 1. 2004-03-29. PMID:14746899. the deposition of tau inclusions is one of the neuropathological hallmarks in neurodegenerative disorders with dementia. 2004-03-29 2023-08-12 human
Patrizia Rizzu, David A Hinkle, Victoria Zhukareva, Vincenzo Bonifati, Lies-Anne Severijnen, Daniel Martinez, Rivka Ravid, Wouter Kamphorst, James H Eberwine, Virginia M-Y Lee, John Q Trojanowski, Peter Heutin. DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Annals of neurology. vol 55. issue 1. 2004-03-12. PMID:14705119. dj-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. 2004-03-12 2023-08-12 Not clear
Bogusław Paradowski, Tadeusz Dobosz, Maria Sasiadek, Małgorzata Szczepania. [Apolipoprotein E and tau protein in vascular dementia]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. vol 15. issue 85. 2004-03-08. PMID:14593964. [apolipoprotein e and tau protein in vascular dementia]. 2004-03-08 2023-08-12 Not clear
Bogusław Paradowski, Tadeusz Dobosz, Maria Sasiadek, Małgorzata Szczepania. [Apolipoprotein E and tau protein in vascular dementia]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. vol 15. issue 85. 2004-03-08. PMID:14593964. in 33 patients meeting the ninds-airen criteria of possible diagnosis of vascular dementia (vd) apoe genotype and tau protein level in cerebrospinal fluid were determined. 2004-03-08 2023-08-12 Not clear
Bogusław Paradowski, Tadeusz Dobosz, Maria Sasiadek, Małgorzata Szczepania. [Apolipoprotein E and tau protein in vascular dementia]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. vol 15. issue 85. 2004-03-08. PMID:14593964. the authors emphasize that apoe e4 and tau protein level determination is not very useful in the differential diagnosis of dementia. 2004-03-08 2023-08-12 Not clear
Jerzy Leszek, Krzysztof Małyszczak, Barbara Janicka, Andrzej Kiejna, Andrzej Wia. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia. Medical science monitor : international medical journal of experimental and clinical research. vol 9. issue 11. 2004-02-20. PMID:14586274. total tau in cerebrospinal fluid differentiates alzheimer's disease from vascular dementia. 2004-02-20 2023-08-12 Not clear
Jerzy Leszek, Krzysztof Małyszczak, Barbara Janicka, Andrzej Kiejna, Andrzej Wia. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia. Medical science monitor : international medical journal of experimental and clinical research. vol 9. issue 11. 2004-02-20. PMID:14586274. the aim of our study was to evaluate the use of csf/ total tau in patients with alzheimer-type dementia (ad) and vascular dementia (vd) compared to controls, in order to investigate. 2004-02-20 2023-08-12 Not clear
Michelangelo Mancuso, Maria Leone, Massimiliano Filosto, Gloria Tognoni, Gabriele Siciliano, Paolo Nichelli, Luigi Murr. P301L Tau mutation and non-Alzheimer dementias in Italy. Acta neurologica Scandinavica. vol 108. issue 5. 2004-01-30. PMID:14616311. p301l tau mutation and non-alzheimer dementias in italy. 2004-01-30 2023-08-12 Not clear
Mark Wagner, Gordon Teichner, David L Bachma. Diagnostic challenges of using CSF assay of tau and beta-amyloid(42) in atypical degenerative dementias of the Alzheimer type. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. vol 18. issue 8. 2004-01-20. PMID:14609583. diagnostic challenges of using csf assay of tau and beta-amyloid(42) in atypical degenerative dementias of the alzheimer type. 2004-01-20 2023-08-12 Not clear
Christopher M Clark, Sharon Xie, Jesse Chittams, Douglas Ewbank, Elaine Peskind, Douglas Galasko, John C Morris, Daniel W McKeel, Martin Farlow, Sharon L Weitlauf, Joseph Quinn, Jeffrey Kaye, David Knopman, Hiroyuki Arai, Rachelle S Doody, Charles DeCarli, Susan Leight, Virginia M-Y Lee, John Q Trojanowsk. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Archives of neurology. vol 60. issue 12. 2004-01-07. PMID:14676043. cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? 2004-01-07 2023-08-12 human
Jeffrey L Cumming. Toward a molecular neuropsychiatry of neurodegenerative diseases. Annals of neurology. vol 54. issue 2. 2004-01-05. PMID:12891666. abnormalities of amyloid beta peptide, alpha-synuclein protein, and hyperphosphorylated tau protein account for more than 90% of degenerative dementias. 2004-01-05 2023-08-12 Not clear
Osamu Yokota, Seishi Terada, Hideki Ishizu, Hiroshi Ujike, Takeshi Ishihara, Masuyuki Namba, Yasuaki Hayashi, Tetsuya Nishinaka, Reiko Namba, Hanae Nakashima, Kenji Uéda, Frédéric Checler, Shigetoshi Kurod. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases. Acta neuropathologica. vol 106. issue 4. 2003-12-17. PMID:12883830. in conclusion, (1) a frontal lobe syndrome-like personality change may be one of the characteristic clinical features of early-onset cwp-ad, (2) the deposition pattern of abeta40 and abeta42 in cwp-ad is more variable than that of presenilin-1-linked cases, (3) abeta deposition can result in development of dementia without tau pathology, and (4) cwp-ad with lbs and several other neurodegenerative disorders with lbs share a common process involving alpha-synuclein and nac deposition. 2003-12-17 2023-08-12 Not clear
Paola Soliveri, Giacomina Rossi, Daniela Monza, Fabrizio Tagliavini, Sylvie Piacentini, Alberto Albanese, Orso Bugiani, Floriano Girott. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Archives of neurology. vol 60. issue 10. 2003-11-25. PMID:14568818. a case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. 2003-11-25 2023-08-12 Not clear
M Riemenschneider, S Wagenpfeil, H Vanderstichele, M Otto, J Wiltfang, H Kretzschmar, E Vanmechelen, H Förstl, A Kur. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Molecular psychiatry. vol 8. issue 3. 2003-11-04. PMID:12660807. phospho-tau/total tau ratio in cerebrospinal fluid discriminates creutzfeldt-jakob disease from other dementias. 2003-11-04 2023-08-12 Not clear
Sonia M Rosso, Laura Donker Kaat, Timo Baks, Marijke Joosse, Inge de Koning, Yolande Pijnenburg, Daniëlle de Jong, Dennis Dooijes, Wouter Kamphorst, Rivka Ravid, Martinus F Niermeijer, Frans Verheij, H P Kremer, Philip Scheltens, Cornelia M van Duijn, Peter Heutink, John C van Swiete. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain : a journal of neurology. vol 126. issue Pt 9. 2003-10-24. PMID:12876142. dementia in one or more first-degree family members was found in 43% of patients and mutation analysis of the tau gene showed mutations in 34 patients (19 p301l, five l315r, four g272v, four r406w, one delta k280 and one s320f), all with a positive family history for dementia (14% of the total population, 32% of patients with a positive family history). 2003-10-24 2023-08-12 Not clear